Last edition
News about "ForDoz Pharma "
Lupin Unveils Doxorubicin Hydrochloride Liposome Injection in US
Lupin has introduced Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials in the United States.
ForDoz Pharma | 31/08/2024 | By Aishwarya | 264
ForDoz Secures US FDA Approval for Doxorubicin Hydrochloride Liposome Injection
Lupin has announced that its alliance partner, ForDoz Pharma Corp. has received approval from US FDA for its Abbreviated New Drug Application for Doxorubicin Hydrochloride Liposome Injection, Single-Dose Vials, to market a generic equivalent of Doxil Liposom.
ForDoz Pharma | 22/07/2024 | By Aishwarya | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy